MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Alnylam Pharmaceuticals Company Profile (NASDAQ:ALNY)

Consensus Ratings for Alnylam Pharmaceuticals (NASDAQ:ALNY) (?)
Ratings Breakdown: 2 Hold Rating(s), 12 Buy Rating(s)
Consensus Rating:Buy (Score: 2.86)
Consensus Price Target: $148.92 (145.71% upside)

Analysts' Ratings History for Alnylam Pharmaceuticals (NASDAQ:ALNY)
Show:
DateFirmActionRatingPrice TargetActions
1/28/2016FBR & Co.Initiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2016FBR & Co.Reiterated RatingOutperform$180.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/19/2016Credit SuisseInitiated CoverageOutperform$154.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/12/2016Cowen and CompanyReiterated RatingOutperform$150.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/5/2016Piper JaffrayReiterated RatingOverweight$184.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/13/2015Needham & Company LLCReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/7/2015Needham & Company LLCInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/7/2015Cowen and CompanyReiterated RatingBuy$150.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/30/2015Leerink SwannReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/26/2015S&P Equity ResearchDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/10/2015Leerink SwannBoost Price TargetOutperform$151.00 -> $152.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/10/2015Jefferies GroupBoost Price TargetBuy$107.00 -> $126.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/8/2015FBR & Co.Reiterated RatingBuy$180.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/4/2015Needham & Company LLCReiterated RatingBuy$152.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/22/2015Jefferies GroupInitiated CoverageBuy$107.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/13/2015FBR & Co.Reiterated RatingBuy$180.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/29/2015Piper JaffrayReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/22/2015Piper JaffrayReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/15/2015Needham & Company LLCReiterated RatingBuy$152.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/31/2015Leerink SwannBoost Price TargetOutperform$145.00 -> $151.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/31/2015Needham & Company LLCReiterated RatingBuy -> Buy$152.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/31/2015Piper JaffrayBoost Price TargetOverweight$180.00 -> $184.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/28/2015JMP SecuritiesReiterated RatingOutperform$144.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/17/2015Leerink SwannReiterated RatingOutperform$145.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/11/2015FBR & Co.Initiated CoverageOutperform$180.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/7/2015Needham & Company LLCReiterated RatingBuy$152.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/7/2015JPMorgan Chase & Co.DowngradeOverweight -> Neutral$125.00 -> $115.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/2/2015Piper JaffrayReiterated RatingOutperform$150.00 -> $180.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/24/2015Deutsche BankSet Price TargetBuy$155.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/24/2015Cowen and CompanySet Price TargetBuy$150.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/24/2015Canaccord GenuityReiterated RatingBuy$160.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/24/2015Needham & Company LLCReiterated RatingBuy$152.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/15/2015Deutsche BankReiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/15/2015Piper JaffrayBoost Price TargetOverweight$155.00 -> $180.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/14/2015Needham & Company LLCReiterated RatingBuy$152.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/12/2015Deutsche BankSet Price TargetBuy$155.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/5/2015Canaccord GenuityReiterated RatingBuy$160.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/26/2015Canaccord GenuityReiterated RatingBuy$160.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/18/2015Canaccord GenuitySet Price TargetBuy$160.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2015Needham & Company LLCSet Price TargetBuy$152.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2015Canaccord GenuitySet Price TargetBuy$160.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/21/2015Leerink SwannBoost Price Target$145.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/21/2015Needham & Company LLCBoost Price TargetBuy$120.00 -> $152.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/16/2015Canaccord GenuityReiterated RatingBuy$160.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/17/2015Janney Montgomery ScottInitiated CoverageBuy$139.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2015BarclaysInitiated CoverageOverweight$125.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/27/2015Cowen and CompanyInitiated CoverageOutperform$150.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2015Canaccord GenuityReiterated RatingBuy$160.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/13/2015Needham & Company LLCSet Price TargetBuy$120.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/8/2015Canaccord GenuitySet Price TargetBuy$160.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/8/2015Deutsche BankBoost Price Target$155.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2015Canaccord GenuityInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/30/2014Goldman SachsInitiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/24/2014JPMorgan Chase & Co.Boost Price TargetOverweight$90.00 -> $106.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/15/2014Piper JaffrayBoost Price TargetOverweight$134.00 -> $158.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/12/2014Goldman SachsInitiated CoverageNeutral$113.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/17/2014Needham & Company LLCBoost Price TargetBuy$94.00 -> $120.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/18/2014Leerink SwannInitiated CoverageOutperform$103.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/14/2014Needham & Company LLCBoost Price TargetBuy$65.00 -> $84.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 2/9/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha